Non-invasive near infrared measurement of blood analyte concentrations

• US 4,882,492 A
• Filed: 01/19/1988
• Issued: 11/21/1989
• Est. Priority Date: 01/19/1988
• Status: Expired due to Fees

• Current Assignee: Sensys Medical, Inc. (Sensys Medical Limited)
• Original Assignee: Biotronics Associates, Inc.
• Inventors: Schlager, Kenneth J.
• Primary Examiner(s): FIELDS, CAROLYN
• Application Number:
  US07/145,459
• Time in Patent Office: 672 Days
• Field of Search: 128/633, 356/39, 356/40, 356/41, 250/345, 250/343, 250/346, 250/341
• US Class Current: 250/346
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: G01J 3/457 Correlation spectrometry, e.g. of the intensity G01J3/453 takes precedence
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427
• CPC Class Codes: G01N 33/48 Biological material, e.g. blood, urine G01N33/02, G01N33/26, G01N33/44, G01N33/46 take precedence; Haemocytometers counting blood corpuscules distributed over a surface by scanning the surface G06M11/02

Abstract

A non-invasive apparatus and related method for measuring the concentration of glucose or other blood analytes utilizes both diffuse reflected and transmissive infrared absorption measurements and may be applied to either in vitro or in vivo sampling. The apparatus and method utilize non-dispersive correlation spectrometry and apply it to liquid blood serum analysis. Spectrally-modified near infrared light from the sample containing the analyte is split into two beams, one of which is directed through a negative correlation filter which blocks light in the absorption bands for the analyte to be measured, and the other of which is directed through a neutral density filter capable of blocking light equally at all wavelengths in the range of interest. Differencing the light intensity between the two light paths provides a measure proportional to analyte concentration.

Claims

1. A method for the non-invasive measurement of the concentration of a blood analyte comprising the steps of:

(a) directing a beam of near infrared light to a source containing the blood analyte to be measured;

(b) causing the beam to be transmitted or reflected by the source so as to provide a spectrally-modified beam;

(c) directing the modified beam into two paths;

(d) directing the modified beam of one path through a first optical filter having an absorption spectra of the analyte sufficient to block light for the maximum expected concentration of the analyte;

(e) directing the modified beam of the other path through a second optical filter having an absorption spectra sufficient to block light equally at all wavelengths;

(f) measuring the relative intensity of the beam from each path exiting its respective optical filter;

(g) generating a signal representative of the difference in intensity between the beams; and

,

(h) converting the signal into an indication of analyte concentration.

2. The method as set forth in claim 1 wherein the first optical filter comprises a solution of the analyte applied to a glass substrate.

3. The method as set forth in claim 1 wherein the analyte is glucose.

4. The method as set forth in claim 3 wherein the near infrared light includes wavelengths in the range of 1800 to 3400 nm and is spectrally modified by reflectance from the source.

5. The method as set forth in claim 3 wherein the near infrared light includes wavelengths in the range of 900 to 1800 nm and is spectrally modified by transmission through the source.

6. The method of claim 1 wherein said source is human tissue and including the step of locating said human tissue is said beam.

7. The method of claim 6 wherein said human tissue has a skin surface layer and said spectrally-modified beam is diffusively reflected from the skin surface layer of the human tissue.

8. The method of claim 6 wherein the light is spectrally modified by transmission through the tissue.

9. The method of claim 8 wherein the analyte is glucose, and selecting said infrared light to detect said glucose.

10. The method of claim 1 including locating a blood serum specimen in said beam as the source and transmitting the light through the blood serum specimen.

11. The method as set forth in claim 10 including selecting said light to have a wavelength to detect an analyte selected from the group consisting of glucose, cholesterol, triglycerides, and uric acid.

12. Apparatus for the non-invasive measurement of the concentration of a blood analyte comprising a source of modulated near infrared light, means for transmitting the light to a blood analyte source containing the blood analyte and for retransmitting spectrallymodified light from the blood analyte source, means for directing the spectrally-modified light into two beams, a first optical filter in the path of one modified beam having an absorption spectra of the analyte sufficient to block light for the maximum expected concentration of the analyte, a second optical filter in the path of the other modified beam having an absorption spectra sufficient to block light equally at all wavelengths, photosensor means in the path of each beam exiting its respective optical filter for converting the light into a signal representative of the intensity of each beam, means for generating a signal representative of the difference in the intensities of the beams, and means for converting the signal representative of the difference into an of analyte concentration.

13. The apparatus as set forth in claim 12 wherein the light transmitting and retransmitting means comprises a fiber optic-linked optrode.

14. The apparatus as set forth in claim 13 wherein the infrared light includes wavelengths in the range of 1800 to 3400 nm.

15. The apparatus as set forth in claim 14 wherein the photosensor means comprises a lead sulfide photodetector.

16. The apparatus as set forth in claim 12 wherein the infrared light includes wavelengths in the range of 900 to 1800 nm.

17. The apparatus as set forth in claim 12 wherein the means for directing the spectrally-modified light into two beams comprises a beam splitter.

18. Apparatus for non-invasive measurement of glucose concentration in human body tissue comprising a source of modulated near infrared light, means for reflectively transmitting the light to the skin surface of the tissue and retransmitting spectrally-modified light diffusely-reflected from the skin surface, means for receiving and directing the spectrally-modified light into two beam paths, a negative correlation filter in one of the paths having a glucose absorption spectra sufficient to block light for the maximum anticipated concentration of glucose, a neutral density filter in the other path having an absorption spectral sufficient to block light equally at all wavelengths, photosensor means for receiving the filtered beams and for converting the same into signals representative of the intensities of the filtered beams, a lock-in amplifier connected to said photosensor means for generating a signal representative of the difference in the intensities of the filtered beams, and a microprocessor connected to said amplifier for calculating the glucose concentration from the differential signal.

19. The apparatus as set forth in claim 18 wherein the means for reflectively transmitting and retransmitting the light comprises a fiber optic-linked optrode.

20. The apparatus as set forth in claim 19 wherein the means for receiving and directing the modified light comprises a beam splitter.

21. The apparatus as set forth in claim 20 wherein the photosensor means comprises a photodetector for each beam.